Belviq Class Action

Belviq (generic name: lorcaserin) is a popular prescription weight-loss drug made by Eisai Inc. to help people experiencing obesity and weight-related health issues curb their hunger. While it is not known exactly how Belviq works, the drug targets a hunger receptor in the brain and helps people fee full after easting smaller amounts of food and also seems to help people fee full longer.

Alarmingly, a U.S. Food and Drug Administration (FDA) safety trial concluded that the drug could increase the risk of several different types of cancer, including pancreatic, lung, and colorectal cancer. Those individuals who participated in the clinical trial reported certain types of cancer with some types occurring more frequently in the lorcaserin group, including pancreatic, colorectal, and lung. As a result, the FDA issued a full Belviq recall in February 2020.

If you or a loved one took Belviq, Belviq XR, or another brand of lorcaserin, and you were diagnosed with cancer, or other serios Belviq side effects, you may be entitled to file a Belviq lawsuit or be included in a Belviq class actoin lawsuit and receive compensation from the drug’s manufacturer. Fill out a free case review form to find out if you are owed money for damages and talk to a Belviq Lawsuit Lawyer about whether you meet the Belviq Lawsuit Criteria and are eligible for a Belviq lawsuit or be a part of the Belviq class action lawsuit today at no charge.

Belviq Class Action

Comments

No comments yet. Why don’t you start the discussion?

Leave a Reply

Your email address will not be published. Required fields are marked *